Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
A Breakthrough Therapy Developed for Investigational Prenatal Treatment ER-004 a Rare Genetic Condition
ER-004, a breakthrough therapy for the prenatal treatment of XLHED, a life-threatening rare genetic condition was developed by EspeRare....
Gvoke HypoPen™ First Autoinjector Discovered for Severe Hypoglycemia
Xeris Pharmaceuticals, Inc discovered novel Gvoke HypoPen™ (glucagon injection),which is used for the treatment of severe hypoglycemia in adults and children with diabetes ages 2 years and above....
GIMOTI™, Novel Nasal Spray Developed for Treatment of Gastroparesisin Adults
GIMOTI™ (metoclopramide), novel nasal spray developed by Evoke Pharma, Inc specifically for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis....
Crysvita - A Breakthrough Therapy Developed For Treatment of TumorInduced Osteomalacia TIO
Crysvita (burosumab-twza) injection the first therapy discovered for the treatment of patients with rare disease, tumor-induced osteomalacia (TIO) corresponding to the age two and older....
Eli Lilly and Company Launched New Rapid Acting Insulin Lyumjev™
Lyumjev™, a new and innovative rapid acting insulin ranging from 100 units/mL and 200 units/mL was launched by Eli Lilly and Company to enhance glycemic control in diabetic patients of type 1 & 2....
A Novel Oral Therapy Discovered to Treat Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Insmed has made a significant discovery in the field of medical treatment by introducing Brensocatib, a breakthrough therapy for adult patients suffering from Non-cystic Fibrosis Bronchiectasis (NCFBE), aimed at reducing exacerbations....
Retevmo™, The First Therapy Developed for Patients with Advanced RET-Driven Lung and Thyroid Cancers
Eli Lilly and Company discovered Retevmo™ (selpercatinib, 40 mg & 80 mg capsules) to treat patients with different types of cancers such as non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer....
SUNOVION Launches KYNMOBI™ for the Treatment of Parkinson's Disease Off Episodes
Sunovion Pharmaceuticals Inc launched a novel drug KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) for the acute and intermittent treatment of off episodes in patients with Parkinson’s disease....
Archer, Inc Launches Next-Generation Sequencing (NGS) Device to Identify NTRK Gene Fusions in Cancer
ArcherDX, Inc has discovered a new next-generation sequencing (NGS) device to detect Neurotrophic Receptor Tyrosine Kinase (NTRK) gene fusions that leads to the formation and growth of cancer....
Deciphera Pharmaceuticals’ Develops QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumors in Adults
Deciphera Pharmaceuticals has developed QINLOCK™ (ripretinib) 50mg capsules for the treatment of advanced gastrointestinal stromal tumour (GIST) in adult patients...
